These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21673810)

  • 1. Isolation and characterization of a metastatic hybrid cell line generated by ER negative and ER positive breast cancer cells in mouse bone marrow.
    Mukhopadhyay KD; Bandyopadhyay A; Chang TT; Elkahloun AG; Cornell JE; Yang J; Goins BA; Yeh IT; Sun LZ
    PLoS One; 2011; 6(6):e20473. PubMed ID: 21673810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
    Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.
    Bandyopadhyay A; Wang L; Chin SH; Sun LZ
    Neoplasia; 2007 Feb; 9(2):113-8. PubMed ID: 17356707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells.
    Amanatullah DF; Tamaresis JS; Chu P; Bachmann MH; Hoang NM; Collyar D; Mayer AT; West RB; Maloney WJ; Contag CH; King BL
    Breast Cancer Res; 2017 Nov; 19(1):121. PubMed ID: 29141657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Different Stemness Markers Identify Different Pools of Cancer Stem Cells in Malignancies: A Study on ER+ and ER-Breast Cancer Cell Lines.
    Chopra S; Goel S; Thakur B; Bhatia A
    Pathol Oncol Res; 2020 Jan; 26(1):371-378. PubMed ID: 30361903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.
    Thompson EW; Sung V; Lavigne M; Baumann K; Azumi N; Aaron AD; Clarke R
    Clin Exp Metastasis; 1999 May; 17(3):193-204. PubMed ID: 10432004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
    Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
    Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
    Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
    J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
    Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
    Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol enhances osteolytic lesions in mice inoculated with human estrogen receptor-negative MDA-231 breast cancer cells in vivo.
    Winding B; Misander H; Høegh-Andersen P; Brünner N; Foged NT
    Breast Cancer Res Treat; 2003 Mar; 78(2):205-16. PubMed ID: 12725420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem-like properties of hormonal therapy-resistant breast cancer cells.
    Uchiumi K; Tsuboi K; Sato N; Ito T; Hirakawa H; Niwa T; Yamaguchi Y; Hayashi SI
    Breast Cancer; 2019 Jul; 26(4):459-470. PubMed ID: 30610551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
    Hiraga T; Ito S; Nakamura H
    Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
    Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
    J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.
    Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL
    Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.
    Mosoyan G; Nagi C; Marukian S; Teixeira A; Simonian A; Resnick-Silverman L; DiFeo A; Johnston D; Reynolds SR; Roses DF; Mosoian A
    PLoS One; 2013; 8(1):e55145. PubMed ID: 23372829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.
    Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Pandey R; Funk JL
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
    Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
    J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
    Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.